Torrent Pharmaceuticals Ltd has entered into a strategic alliance with Boehringer Ingelheim India Pvt Ltd to co-market Cospiaq®, Cospiaq Met™ and Xilingio® in India.
OPPI elects S Sridhar as new President
OPPI elects S Sridhar as new President
15 February 2021 | News Sridhar is the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India
The Organisation of Pharmaceutical Producers of India (OPPI) has elected S Sridhar as its next President. The term is for a period of two years and is effective from February 15, 2021. He takes over from Sharad Tyagi, Former Managing Director, Boehringer Ingelheim India Pvt Ltd. Sridhar is the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India. Sridhar has been a member of the Executive Committee of OPPI for the past six years and has also chaired its Finance and Taxation Work Group. Sridhar is a strong voice of healthcare transformation in the country and was the chair of FICCI’s Pharma Committee till recently.
OPPI elects S Sridhar as new President
OPPI elects S Sridhar as new President
15 February 2021 | News Sridhar is the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India
The Organisation of Pharmaceutical Producers of India (OPPI) has elected S Sridhar as its next President. The term is for a period of two years and is effective from February 15, 2021. He takes over from Sharad Tyagi, Former Managing Director, Boehringer Ingelheim India Pvt Ltd. Sridhar is the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India. Sridhar has been a member of the Executive Committee of OPPI for the past six years and has also chaired its Finance and Taxation Work Group. Sridhar is a strong voice of healthcare transformation in the country and was the chair of FICCI’s Pharma Committee till recently.